ID

39680

Beskrivning

Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir; ODM derived from: https://clinicaltrials.gov/show/NCT01598090

Länk

https://clinicaltrials.gov/show/NCT01598090

Nyckelord

  1. 2020-02-09 2020-02-09 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

9 februari 2020

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Hepatitis C Virus NCT01598090

Eligibility Hepatitis C Virus NCT01598090

Criteria
Beskrivning

Criteria

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
chronic hepatitis c genotype 1. gt-1b capped at 50 % of naïve subjects
Beskrivning

Chronic Hepatitis C Genotype

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0524910
UMLS CUI [1,2]
C1533728
naives to prior anti-hcv therapy [interferon (ifn) and direct antiviral agent (daa) based]
Beskrivning

Anti-hepatitis C (HCV) Agents Absent | Interferon Absent | DIRECT ACTING ANTIVIRALS Absent

Datatyp

boolean

Alias
UMLS CUI [1,1]
C4324240
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C3652465
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C3653501
UMLS CUI [3,2]
C0332197
relapsers (defined as subjects who had undetectable hcv ribonucleic acid (rna) on prior treatment regimen of alfa-2a/rbv and hepatitis c virus (hcv) rna > 25iu/ml after discontinuation of treatment). capped at 20%
Beskrivning

Recurrent disease | Hepatitis C virus RNA Undetectable | Status post Interferon Alfa-2a Ribavirin | Hepatitis C virus RNA assay | Status post Therapeutic procedure Discontinued

Datatyp

boolean

Alias
UMLS CUI [1]
C0277556
UMLS CUI [2,1]
C0369335
UMLS CUI [2,2]
C3827727
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C0021734
UMLS CUI [3,3]
C0035525
UMLS CUI [4]
C1272251
UMLS CUI [5,1]
C0231290
UMLS CUI [5,2]
C0087111
UMLS CUI [5,3]
C1444662
hcv rna ≥ 100,000 iu/ml
Beskrivning

Hepatitis C virus RNA assay

Datatyp

boolean

Alias
UMLS CUI [1]
C1272251
subjects with compensated cirrhosis can be enrolled and will be capped at approximately 10%
Beskrivning

Compensated cirrhosis

Datatyp

boolean

Alias
UMLS CUI [1]
C1608426
seronegative for human immunodeficiency virus (hiv) and hepatitis b surface antigen (hbsag)
Beskrivning

HIV Seronegative | Hepatitis B Surface Antigens Seronegative

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0019682
UMLS CUI [1,2]
C0521144
UMLS CUI [2,1]
C0019168
UMLS CUI [2,2]
C0521144
men or women, 18-70 years of age
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
chronic liver disease due to causes other than chronic hcv
Beskrivning

Chronic liver disease | Etiology Except Chronic Hepatitis C

Datatyp

boolean

Alias
UMLS CUI [1]
C0341439
UMLS CUI [2,1]
C0015127
UMLS CUI [2,2]
C0332300
UMLS CUI [2,3]
C0524910
current or past evidence of decompensation
Beskrivning

Decompensation

Datatyp

boolean

Alias
UMLS CUI [1]
C0231187
conditions that preclude the use of alfa/rbv/tvr per respective labels
Beskrivning

Condition Excludes Interferon-alpha | Condition Excludes Ribavirin | Condition Excludes Telaprevir

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0002199
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C0332196
UMLS CUI [2,3]
C0035525
UMLS CUI [3,1]
C0348080
UMLS CUI [3,2]
C0332196
UMLS CUI [3,3]
C1876229
diagnosed or suspected hepatocellular carcinoma
Beskrivning

Liver carcinoma | Liver carcinoma Suspected

Datatyp

boolean

Alias
UMLS CUI [1]
C2239176
UMLS CUI [2,1]
C2239176
UMLS CUI [2,2]
C0750491

Similar models

Eligibility Hepatitis C Virus NCT01598090

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Item Group
C1512693 (UMLS CUI)
Chronic Hepatitis C Genotype
Item
chronic hepatitis c genotype 1. gt-1b capped at 50 % of naïve subjects
boolean
C0524910 (UMLS CUI [1,1])
C1533728 (UMLS CUI [1,2])
Anti-hepatitis C (HCV) Agents Absent | Interferon Absent | DIRECT ACTING ANTIVIRALS Absent
Item
naives to prior anti-hcv therapy [interferon (ifn) and direct antiviral agent (daa) based]
boolean
C4324240 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C3652465 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C3653501 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Recurrent disease | Hepatitis C virus RNA Undetectable | Status post Interferon Alfa-2a Ribavirin | Hepatitis C virus RNA assay | Status post Therapeutic procedure Discontinued
Item
relapsers (defined as subjects who had undetectable hcv ribonucleic acid (rna) on prior treatment regimen of alfa-2a/rbv and hepatitis c virus (hcv) rna > 25iu/ml after discontinuation of treatment). capped at 20%
boolean
C0277556 (UMLS CUI [1])
C0369335 (UMLS CUI [2,1])
C3827727 (UMLS CUI [2,2])
C0231290 (UMLS CUI [3,1])
C0021734 (UMLS CUI [3,2])
C0035525 (UMLS CUI [3,3])
C1272251 (UMLS CUI [4])
C0231290 (UMLS CUI [5,1])
C0087111 (UMLS CUI [5,2])
C1444662 (UMLS CUI [5,3])
Hepatitis C virus RNA assay
Item
hcv rna ≥ 100,000 iu/ml
boolean
C1272251 (UMLS CUI [1])
Compensated cirrhosis
Item
subjects with compensated cirrhosis can be enrolled and will be capped at approximately 10%
boolean
C1608426 (UMLS CUI [1])
HIV Seronegative | Hepatitis B Surface Antigens Seronegative
Item
seronegative for human immunodeficiency virus (hiv) and hepatitis b surface antigen (hbsag)
boolean
C0019682 (UMLS CUI [1,1])
C0521144 (UMLS CUI [1,2])
C0019168 (UMLS CUI [2,1])
C0521144 (UMLS CUI [2,2])
Age
Item
men or women, 18-70 years of age
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Chronic liver disease | Etiology Except Chronic Hepatitis C
Item
chronic liver disease due to causes other than chronic hcv
boolean
C0341439 (UMLS CUI [1])
C0015127 (UMLS CUI [2,1])
C0332300 (UMLS CUI [2,2])
C0524910 (UMLS CUI [2,3])
Decompensation
Item
current or past evidence of decompensation
boolean
C0231187 (UMLS CUI [1])
Condition Excludes Interferon-alpha | Condition Excludes Ribavirin | Condition Excludes Telaprevir
Item
conditions that preclude the use of alfa/rbv/tvr per respective labels
boolean
C0348080 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0002199 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
C0035525 (UMLS CUI [2,3])
C0348080 (UMLS CUI [3,1])
C0332196 (UMLS CUI [3,2])
C1876229 (UMLS CUI [3,3])
Liver carcinoma | Liver carcinoma Suspected
Item
diagnosed or suspected hepatocellular carcinoma
boolean
C2239176 (UMLS CUI [1])
C2239176 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial